Peter Staller

3.2k total citations · 1 hit paper
12 papers, 2.6k citations indexed

About

Peter Staller is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Peter Staller has authored 12 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Peter Staller's work include Cancer-related Molecular Pathways (5 papers), Epigenetics and DNA Methylation (4 papers) and Ubiquitin and proteasome pathways (3 papers). Peter Staller is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Epigenetics and DNA Methylation (4 papers) and Ubiquitin and proteasome pathways (3 papers). Peter Staller collaborates with scholars based in Germany, Denmark and United States. Peter Staller's co-authors include Martin Eilers, Wilhelm Krek, Holger Moch, Joanna Lisztwan, Edward J. Oakeley, Joan Massagué, Joan Seoane, Caroline Bouchard, Célio Pouponnot and K.S. Jensen and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Peter Staller

12 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL

2003 693 citations Peter Staller, Joanna Lisztwan et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Staller Germany	12	1.9k	886	653	410	246	12	2.6k
Angera H. Kuo United States	18	1.6k 0.8×	902 1.0×	565 0.9×	464 1.1×	335 1.4×	23	2.6k
Ichiro Nakano United States	28	1.9k 1.0×	798 0.9×	738 1.1×	504 1.2×	165 0.7×	34	2.8k
Heather Maecker United States	14	1.7k 0.9×	1.2k 1.4×	587 0.9×	852 2.1×	185 0.8×	18	3.0k
Nabendu Pore United States	17	1.4k 0.7×	614 0.7×	1.1k 1.6×	244 0.6×	287 1.2×	26	2.3k
Marina Holgado-Madruga United States	24	2.4k 1.3×	1.1k 1.2×	378 0.6×	534 1.3×	293 1.2×	33	3.3k
Susanne Walz Germany	20	1.6k 0.8×	970 1.1×	453 0.7×	653 1.6×	181 0.7×	23	2.5k
Laura Lintault United States	7	2.3k 1.2×	877 1.0×	1.4k 2.1×	347 0.8×	163 0.7×	8	3.1k
Paul Meltzer United States	7	1.8k 0.9×	768 0.9×	824 1.3×	233 0.6×	235 1.0×	10	2.4k
Robin E. Bachelder United States	22	1.7k 0.9×	1.2k 1.3×	573 0.9×	320 0.8×	160 0.7×	37	2.6k
Olga A. Guryanova United States	17	2.0k 1.0×	645 0.7×	1.1k 1.6×	281 0.7×	258 1.0×	36	3.0k

Countries citing papers authored by Peter Staller

Since Specialization

Citations

This map shows the geographic impact of Peter Staller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Staller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Staller more than expected).

Fields of papers citing papers by Peter Staller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Staller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Staller. The network helps show where Peter Staller may publish in the future.

Co-authorship network of co-authors of Peter Staller

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Staller. A scholar is included among the top collaborators of Peter Staller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Staller. Peter Staller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Paroni, Gabriela, Marco Bolis, Adriana Zanetti, et al.. (2018). HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases. Oncogene. 38(15). 2675–2689. 21 indexed citations

2.

Rasmussen, Peter Birk & Peter Staller. (2014). The Kdm5 Family of Histone Demethylases as Targets in Oncology Drug Discovery. Epigenomics. 6(3). 277–286. 81 indexed citations

3.

Coffey, Kelly, Lynsey Rogerson, Jacqueline Stockley, et al.. (2013). The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover. Nucleic Acids Research. 41(8). 4433–4446. 99 indexed citations

4.

Jensen, K.S., Tina Binderup, Klaus T. Jensen, et al.. (2011). FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function. The EMBO Journal. 30(22). 4554–4570. 103 indexed citations

5.

Beyer, Sophie, Malene M. Kristensen, K.S. Jensen, Jens Vilstrup Johansen, & Peter Staller. (2008). The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF. Journal of Biological Chemistry. 283(52). 36542–36552. 280 indexed citations

6.

Struckmann, Kirsten, Kirsten D. Mertz, Martina Storz, et al.. (2008). pVHL co‐ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear‐cell renal cell carcinoma. The Journal of Pathology. 214(4). 464–471. 62 indexed citations

7.

Staller, Peter, et al.. (2003). Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL. Nature. 425(6955). 307–311. 693 indexed citations breakdown →

8.

Staller, Peter, Astrid Kiermaier, Joan Seoane, et al.. (2001). Repression of p15INK4b expression by Myc through association with Miz-1. Nature Cell Biology. 3(4). 392–399. 465 indexed citations

9.

Seoane, Joan, et al.. (2001). TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nature Cell Biology. 3(4). 400–408. 395 indexed citations

10.

Elliott, Katherine J., Daitoku Sakamuro, Wei Du, et al.. (1999). Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms. Oncogene. 18(24). 3564–3573. 98 indexed citations

11.

Bouchard, Caroline, Peter Staller, & Martin Eilers. (1998). Control of cell proliferation by Myc. Trends in Cell Biology. 8(5). 202–206. 203 indexed citations

12.

Haas, Kirsten, Peter Staller, Christoph Geisen, et al.. (1997). Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc. Oncogene. 15(2). 179–192. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact